• 2023 Keynote Speaker. HLA-B27 and beyond: AxSpA Pathogenesis. Thurston Arthritis Research Center (TARC) Research Day. Chappel Hill, NC, USA.

  • 2023 Invited Speaker. The new age of spondyloarthritis care: unpacking 2 decades of transformation in an ancient disease. Medicine Grand Rounds. University of North Carolina, Chappel Hill, NC, United States.

  • 2023 Invited Speaker. On the road to MIF-Directed Therapies. Workshop on Translational Medicine in Rheumatic Diseases. Porto, Portugal.

  • 2023 Invited Speaker. Potential Role of HLA-B27 in the Pathogenesis of AxSpA: What is New? HLA-B27 50 Year Celebrations. Spondyloarthritis Research and Treatment Network, Annual Meeting. Cleveland, Ohio, United States.

  • 2023 Invited Speaker. Advances in treatment of AxSpA. MEDECON World Congress AKMG Emirates CME. Dubai, Dubayy [Dubai], United Arab Emirates.

  • 2023 Invited Speaker. MIF: A promising therapeutic target in AxSpA. International generics of AS (IGAS). Naples, Italy.

  • 2022 Invited Speaker. MIF-neutrophil-bone axis in AS pathogenesis. International Congress of Spondyloarthritis. Belgium.

  • 2022 Invited Speaker. Pathogenesis of SpA, rheumatology-dermatology perspectives. Kuwait Rheumatology. Kuwait.

  • 2022 Invited Speaker. Pathogenesis of AxSpA. Yale State of the Art Seminars. United States.

  • 2022 Invited Speaker. Advances in pathogenesis and treatment of AxSpA. Congress of Clinical Rheumatology. Destin, Florida, United States.

  • 2021 Invited Speaker. Advances in Axial Spondyloarthritis 2021. Wiley China. China.

  • 2021 Invited Speaker. Advances in Pathogenesis of Axial Spondyloarthritis. Turkish Rheumatology Association. Turkey.

  • 2021 Invited Lecturer. Approach to back pain and Treatment advances in Spondyloarthritis. Association of Kerala Medical Graduates. United States.

  • 2020 Keynote Speaker. Course of Axial Spondyloarthritis and Psoriatic Arthritis. Columbian Rheumatology Association. Colombia.

  • 2020 Keynote Speaker. Ankylosing spondylitis decoded : Advance in treatment and Promise for the future. Antardhwani, AS Patient support group. India.

  • 2020 Invited Speaker. Immunopathology and Cytokine Storm in Covid19. Qatar Rheumatology Association. Qatar.

  • 2020 Invited Speaker. How does spinal fusion happen in AS? Is this amenable to modification? Pan American League of Association for Rheumtaology (PANLAR). Miami, Florida, United States.

  • 2020 Invited Speaker. How divergent thinking lead to a Novel discovery on Ankylosing Spondylitis. 15th Grand Alumni Convention: Trivandrum Medical College. Kerala, India.

  • 2020 Invited Speaker. Recent Advances in AxSPA. Emirates Rheumatology Academy. Dubayy [Dubai], United Arab Emirates.

  • 2019 Invited Speaker. Clinical Approach to SpA. Spondyloarthritis Research and Treatment Network, Annual Meeting. Boston, Massachusetts, United States.

  • (2018) From NSAIDs to Biologic DMARDs: what is new in SpA. Annual Bahrain Rheumatology Conference, Manama, Bahrain.
  • (2018) Non-radiographic axial SpA: The concept, disease burden and principles of treatment. 6th World Congress on Controversies, Debates & Consensus in Bone, Muscle & Joint Diseases (BMJD). Bangkok, Thailand.
  • (2018) Anti IL17 therapy in axial SpA. Monsoon Rheumatology Summit, Cochin, India.
  • (2018) Pathological bone formation in AS – human studies. Spondyloarthritis Research and Treatment Network, Annual Meeting, Boston, USA.
  • (2018) Advances in treatment of ankylosing spondylitis. Arab League Against Rheumatism (ArLAR), Muscat, Oman.
  • (2018) Visiting Professor, Immunology for Clinicians, University of British Columbia, Vancouver, Canada
  • (2017). Cardiovascular risk and co-morbidities in axial spondyloarthritis. SPARTAN-GRAPPA-ASAS Educational Symposium on Axial Spondyloarthritis (axSpA) and Psoriatic Arthritis (PsA), San Diego, United States
  • (2017) Role of MIF in Ankylosing Spondylitis pathogenesis. International Genetics of Ankylosing Spondylitis 2017. Palermo, Italy.
  • (2017). Recent advances in pathogenesis of Ankylosing Spondylitis. 2017 BRIESE: BC Rheumatology Invitational Education Series, Vancouver, Canada
  • (2017). Disease modification in AS. BC Rheumatology Invitational Education Series: BRIESE 2017, Vancouver, Canada
  • (2017). Pathogenesis of Spondyloarthritis. Spondyloarthritis Forum, King Khalid University, Riyadh, Saudi Arabia
  • (2017). Changing paradigm of inflammation and new bone formation in AS. RHEUMATOLOGY ROUNDS: Western University, London, Ontario, Canada
  • (2017). Non-Radiographic Axial Spondyloarthritis: Clinical and Therapeutic Advances. Spondylitis Forum, King Khalid University, Riyadh, Saudi Arabia
  • (2017). Recent advances in management of psoriatic arthritis. Association des medecins rhumatologues du Quebec: AMRQ 2017, Estereel, Quebec, Canada
  • (2017). Biomarkers in AS: Predictors of Progression. University of Calgary Spondyloarthritis Research Workshop, Calgary, Canada
  • (2017). Immunology 101. Canadian Rheumatology Association Residents Course, Ottawa, Canada
  • (2017). Spondyloarthritis Assessment. Canadian Rheumatology Association Residents’ Course, Ottawa, Canada
  • (2016). Inflammation, New bone formation and Disease Modification in Ankylosing Spondylitis. Medical Grand Rounds Queen’s University, Kingston, Canada
  • (2016). Tomorrow’s Treatment of Spondyloarthritis. Ontario Rheumatology Association Annual Conference, Muskoka, Canada
  • (2016). Inflammatory Back Pain. Inter-professional Approach to Back Pain Assessment and Rehabilitation, Canada
  • (2016). Recent advances in immunopathogenesis of Ankylosing spondylitis and implications on treatment in the next decade. Université de Montréal, Hôpital Notre-Dame du CHUM. Grand Rounds, Montreal, Canada
  • (2016). Recent advances in immunopathogenesis of Ankylosing spondylitis and implications on treatment in the next decade.Rounds, Centre Hospitalier de l’Université de Montréal, Canada
  • (2016). Radiology in Axial Spondyloarthritis. Dokuz Eylül University. National Consensus Meeting on Imaging in SpA, Izmir, Turkey
  • (2016). Advances in Pathogenesis of AS. Turkish Rheumatology Association, Izmir, Turkey
  • (2016). Tales from translational studies in Ankylosing Spondylitis. Spondyloarthritis Research Consortium of Canada Annual Meeting, Toronto, Canada.
  • (2015). Interpretation of X-rays for assessment of back pain.Imaging Workshop in AS: Training Turkish Rheumatologists in X-ray, CT and MRI interpretation for standardizing assessment in AS., Turkey
  • (2015). Radiographic progression in AS: From Molecules to Modification.International Spondyloarthritis Meeting, Palermo, Italy
  • (2015). Recent advances in pathogenesis and management of axial spondyloarthritis. Grand Rounds, Division of Rheumatology. Western University, London, Ontario, Canada
  • (2015). Antigen presentation, MHC-TCR interaction.Immunology Workshop for Clinicians. Asia Pacific League Against Rheumatism (APLAR)., Chennai, India
  • (2015). Autophagy in Ankylosing Spondylitis.Spondyloarthritis Research and Training Network (SPARTAN), Denver, United States
  • (2015). Disease Modification in Ankylosing Spondylitis.Asia Pacific League Against Rheumatism (APLAR), Chennai, India
  • (2015). Biologic Response Modifiers: Mechanism of action. Immunology Workshop for Clinicians. Asia Pacific League Against Rheumatism (APLAR). India
  • (2014). Making Sense of Spondyloarthritis. Canadian Rheumatology Association 2014, Whistler, Whistler, Canada
  • (2014). Recent Advances in the Pathogenesis and Treatment of Axial Spondyloarthritis. University of Manitoba Arthritis Centre Rounds, Canada
  • (2014). Update on Ankylosing Spondylitis. Ontario Rheumatology Association, Canada
  • (2014). ERAP1 Variants Associated with Ankylosing Spondylitis Alter the Unfolded Protein Response in Cells Expressing HLA-B27. Canadian Rheumatology Association 2014, Whistler, Canada
  • (2014). Osteoproliferation in AS and PsA: Challenges and Advances.Spondyloarthritis Research and Training Network (SPARTAN) and Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) combined meeting, United States
  • (2013). Advances in pathogenesis and treatment of ankylosing spondylitis.All Kerala Medical Graduates Convention CME, Houston, United States
  • (2013). Pathogenesis and Management of Ankylosing Spondylitis. Sanjay Gandhi Postgraduate Institute of Medical Sciences, 25th Anniversary CME, Lucknow, India
  • (2013). Recent Advances in Spondyloarthritis.Trivandrum Orthopedic Club – Kerala Orthopedic Society, Trivandrum, India
  • (2013). Recent advances in pathogenesis and treatment of ankylosing spondylitis. Rheumatology Grand Rounds, McMaster University, Hamilton, Canada
  • (2013). What is coming after TNFi in axial SpA? NSAIDs again or new drugs?. European League Against Rheumatism, Madrid, Spain
  • (2013). Treatment of non-radiographic axial spondyloarthritis. Indian Rheumatology Association Annual Scientific Meeting, Calcutta, India
  • (2013). Radiographic progression in ankylosing spondylitis. Taiwan Rheumatology Association Symposium, Taichung, Taiwan, Province of China
  • (2013). Can we prevent osteoproliferation in AS.Spondyloarthritis Research and Treatment Network 2013, San Francisco, United States
  • (2013). Recent advances in pathogenesis and treatment of axial spondyloarthritis (Ranked Best Rounds of the Year). Rheumatology Grand Rounds, University of Western, London, Ontario, London, Canada
  • (2012). Advances in pathogenesis and treatment of ankylosing spondylitis. Indian Rheumatology Association. Annual Scientific Meeting, Ahmedabad, India
  • (2012). Pathogenesis and Management of Axial Spondyloarthritis.Indian Institute of Spinal Injuries CME, New Delhi, India
  • (2012). Advances in the pathogenesis of ankylosing spondylitis. Amrita Institute of Medical Sciences Workshop, Cochin, India